In previous posts I discussed the patent infringement suit brought by Danish biotech Novozymes against its rival Danisco (recently acquired by DuPont).
Specifically, Novozymes sued Danisco in May 2010 in the Western District of Wisconsin, alleging infringement of U.S. Patent No. 7,713,723 (’723